Spike proteins are one of the main targets for COVID-19 vaccines and treatments. But those remedies gradually lose effectiveness when the spike proteins mutate. Now, researchers report in ACS Central Science that they have discovered small molecules that target other segments that mutate less.
A Cornell University economist conducted an experiment with nearly 700 people in three countries to gauge the public’s perception of relative risk factors.
An analysis led by Brown University researchers showed that work shift is an important factor to consider when designing workplace health interventions.
Crowded places tend to be a hub for infectious disease transmission. The COVID-19 pandemic has shown us that it is necessary to find ways to manage crowded areas to help curtail the spread of infectious diseases.
Researchers recently modeled the transmission of COVID-19 within an isolation room at the Royal Brompton Hospital in London, U.K. Their goal was to explore the optimal room layout to reduce the risk of infection for health care staff. To accomplish this, they used an adaptive mesh finite-element computational fluid dynamics model to simulate 3D spatial distribution of the virus within the room — based on data collected from the room during a COVID-19 patient’s stay. They share their findings and guidance in Physics of Fluids.
People who know someone who became ill with COVID-19 or died from the disease are twice as likely to receive a COVID-19 vaccine, according to a study led by Rutgers and Penn State University.
Few studies have evaluated the waning of vaccine effectiveness against severe outcomes caused by SARS-CoV-2 Omicron infection. Hong Kong is providing inactivated and mRNA vaccines, but the population had limited protection from natural infections before the Omicron variant emerged.
Labor statistics show long Covid is having a significant impact on American's ability to return to work. Hackensack Meridian's Covid Recovery Center discusses treatments they offer and how it has helped patients return to their normal lives.
Breakthrough COVID-19 infections after vaccination occurred in 7.5% of Texans surveyed and higher odds were associated with Hispanic ethnicity, larger household size, rural versus urban living, type of vaccination, and multiple comorbidities, according to findings from UTHealth Houston School of Public Health published today in the Journal of Infectious Diseases.
The tuberculosis vaccine (or BCG vaccine) does not protect elderly with co-morbidities against disease symptoms caused by a coronavirus infection.
Pia Pannaraj, MD, MPH, an infectious disease specialist at Children's Hospital Los Angeles, was awarded $4.2 million from the National Institutes of Health to study COVID-19 immunity in children.
People with weakened immune systems remain more likely to die if hospitalised with COVID-19 than patients with normal immune systems, a new UK study has confirmed.
Cornell University researchers have found white-tailed deer – the most abundant large mammal in North America – are harboring SARS-CoV-2 variants that were once widely circulated, but no longer found in humans.
Research findings published in Frontiers in Immunology show that cancer immunotherapy does not interfere with COVID-19 immunity in previously vaccinated patients. These findings support recommending vaccination for patients with cancer, including those receiving systemic therapies, say Saint Louis University scientists.
Testing plays a crucial role in humanity’s strategy to mitigate the effects of widespread COVID-19 infection. However, given multiple options for testing and the emergence of the highly contagious Omicron variant, how do we choose which test to use?
Lockdown measures aimed at slowing the spread of COVID-19 had the unintended benefit of curtailing violence by the insurgent group ISIS, according to a new study led by Yale political scientist Dawn Brancati.
A booster (third) dose of a SARS-CoV-2 vaccine was associated with a 90% reduction in death in people with multiple health conditions compared to 2 doses, according to a new study from Hong Kong published in CMAJ (Canadian Medical Association Journal).
The main point of the study, which was completed before other variants came on the scene, is for pregnant women to get vaccinated and receive all their boosters, including the bivalent booster.
At the beginning of the COVID-19 pandemic, Joachim Kock, mathematician at the Universitat Autònoma de Barcelona (UAB), began to experiment with epidemiological models. He did not improve upon the predictions, but unexpectedly he made a mathematical discovery that led to the solution of an old problem in theoretical computer science, open since the 1980s, on Petri nets.
Three years ago this month, the first case of COVID was diagnosed in the United States. Here are the latest figures on the pandemic, collected by UCLA Health hospitals and clinics.
As its 11th-anniversary approaches, the National Primate Research Center of Thailand Chulalongkorn University (NPRCT-CU) and the Primates Enterprise Co., Ltd. are pleased to announce two events in February 2023:
A new COVID-19 vaccine based on a different platform than current vaccines on the market has been tested in humans for the first time by researchers at Radboud university medical center.
The number of people dying from cardiovascular disease (CVD) in the U.S. escalated during the first year of the COVID-19 pandemic, from 874,613 CVD-related deaths recorded in 2019 to 928,741 in 2020.
In the early pandemic, conspiracy theories that were shared the most on Twitter highlighted malicious purposes and secretive actions of supposed bad actors behind the crisis, according to an analysis of nearly 400,000 posts.
Argonne’s expertise in biosafety, genetic sequencing and epidemiology help public health officials track which COVID variants are present in Illinois and monitor variants of concern.
New research finds a high variation between how pandemic mitigation measures affected immigration to different destination countries, from a slight increase to huge reductions.
Below is a brief roundup of news and story ideas from the experts at UCLA Health.
Wisconsin virologists have outlined in atomic detail the intricate RNA replication machines that coronaviruses create inside infected cells, giving rise to potential new strategies to fight disease.
The Wildlife Conservation Society (WCS) released an image of scientists taking a swab from a straw-colored fruit bat (Eidolon helvum) to test it for zoonotic diseases such as the Ebola virus.
Cardiologists and surgeons from the Smidt Heart Institute at Cedars-Sinai are available for interviews during Heart Month on an array of cardio-related topics.
The federally funded COVID-19 Prevention Network was instrumental in the rapid development of safe, effective and lifesaving COVID-19 vaccines during earlier phases of the pandemic. This vital work to expedite Phase 3 clinical trials also resulted in a 'treasure trove' of data, thanks to a highly collaborative and harmonized approach that can serve as a national and even international model for major research initiatives while also guiding responses to future public health emergencies.
Researchers at University of California San Diego and UC Riverside have further elucidated the molecular pathway used by the SARS-CoV-2 virus to infect human lung cells, identifying a key host-cell player that may prove a new and enduring therapeutic target for treating COVID-19.
Using prenatal magnetic resonance imaging, a group of MedUni Vienna researchers examined the placentas and foetuses of women who tested positive for SARS-CoV-2 during pregnancy.
An increase in anti-Chinese sentiment has led to consumer discrimination against Asian American-owned small businesses, according to new Ross School of Business research.
The proportion of opioid overdose deaths involving buprenorphine, a medication used to treat opioid use disorder, did not increase in the months after prescribing flexibilities were put in place during the COVID-19 pandemic, according to a new study.
Nearly half a million people missed out on starting medication to lower their blood pressure during the Covid-19 pandemic, according to research supported by the British Heart Foundation (BHF) Data Science Centre at Health Data Research UK published today in Nature Medicine [1].
In this study of 1,832 U.S. adults, the risk of reporting symptoms for 28 or more days after COVID-19 onset was significantly higher in participants who were unvaccinated at the time of infection and those who reported moderate or severe acute illness symptoms.
If pharmaceutical companies shared their intellectual property rights to vaccines with the global community, millions of lives could be saved in future pandemics, according to a new paper co-authored by faculty at Binghamton University, State University of New York.
COVID-19 interrupted or delayed medical treatment for many people who chose to put off elective procedures or couldn't get in to see a specialist.
The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has published in the journal Lancet the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries, including Ann & Robert H. Lurie Children’s Hospital of Chicago.
Just as a highly transmissible variant prompts officials to extend COVID-19 emergency status, one of the largest surveys ever conducted shows people are more willing to get vaccinated when health workers reveal how many others are doing so.
COVID-19 is changing household behaviors related to how we are exposed to various household chemicals linked to poor health outcomes.
A new study led by scientists at La Jolla Institute for Immunology (LJI) shows how ideal antibodies against SARS-CoV-2 hit their marks. Now scientists are looking at how we might harness their power in new antibody therapeutics and even more effective COVID-19 vaccines.
A novel peptide designed by University of California, Irvine researchers has been found to suppress the damaging lung inflammation seen in acute respiratory distress syndrome, or ARDS. Their study, which appears in iScience, describes the first specific treatment designed to prevent the deadly disease, which can appear in patients with severe lung injury from infections with bacteria and viruses, like pneumonia, flu, respiratory syncytial virus (RSV) and COVID-19.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
